메뉴 건너뛰기




Volumn 136, Issue 6, 2015, Pages 1160-1164

Thrombophilia testing patterns amongst patients with acute venous thromboembolism

Author keywords

Genetic testing; Hereditary; Multiphasic screening; Thrombophilia; Thrombosis; Venous thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN; ANTICOAGULANT AGENT;

EID: 84949294076     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2015.10.019     Document Type: Article
Times cited : (18)

References (27)
  • 1
    • 0642372646 scopus 로고    scopus 로고
    • Pros and cons of thrombophilia testing: Cons
    • S.J. Machin Pros and cons of thrombophilia testing: cons J. Thromb. Haemost. 1 2003 412 413
    • (2003) J. Thromb. Haemost. , vol.1 , pp. 412-413
    • Machin, S.J.1
  • 2
    • 84884860407 scopus 로고    scopus 로고
    • Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups
    • V. De Stefano, and E. Rossi Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups Thromb. Haemost. 110 2013 697 705
    • (2013) Thromb. Haemost. , vol.110 , pp. 697-705
    • De Stefano, V.1    Rossi, E.2
  • 3
    • 0033539096 scopus 로고    scopus 로고
    • The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor v Leiden and the G20210A prothrombin mutation
    • V. De Stefano, I. Martinelli, P.M. Mannucci, and et al. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation N. Engl. J. Med. 341 1999 801 806
    • (1999) N. Engl. J. Med. , vol.341 , pp. 801-806
    • De Stefano, V.1    Martinelli, I.2    Mannucci, P.M.3
  • 4
    • 67649160484 scopus 로고    scopus 로고
    • Predictive value of factor v Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: A systematic review
    • J.B. Segal, D.J. Brotman, A.J. Necochea, and et al. Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review JAMA 301 2009 2472 2485
    • (2009) JAMA , vol.301 , pp. 2472-2485
    • Segal, J.B.1    Brotman, D.J.2    Necochea, A.J.3
  • 6
    • 0030317948 scopus 로고    scopus 로고
    • The long-term clinical course of acute deep venous thrombosis
    • P. Prandoni, A.W. Lensing, A. Cogo, and et al. The long-term clinical course of acute deep venous thrombosis Ann. Intern. Med. 125 1996 1 7
    • (1996) Ann. Intern. Med. , vol.125 , pp. 1-7
    • Prandoni, P.1    Lensing, A.W.2    Cogo, A.3
  • 8
    • 0042658340 scopus 로고    scopus 로고
    • Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: Prospective cohort study
    • T. Baglin, R. Luddington, K. Brown, and C. Baglin Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study Lancet 362 2003 523 526
    • (2003) Lancet , vol.362 , pp. 523-526
    • Baglin, T.1    Luddington, R.2    Brown, K.3    Baglin, C.4
  • 9
    • 0037111813 scopus 로고    scopus 로고
    • The risk of recurrent venous thromboembolism in heterozygous carriers of factor v Leiden and a first spontaneous venous thromboembolism
    • S. Eichinger, A. Weltermann, C. Mannhalter, and et al. The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism Arch. Intern. Med. 162 2002 2357 2360
    • (2002) Arch. Intern. Med. , vol.162 , pp. 2357-2360
    • Eichinger, S.1    Weltermann, A.2    Mannhalter, C.3
  • 10
    • 0034994092 scopus 로고    scopus 로고
    • The risk of recurrent venous thromboembolism among heterozygous carriers of the G20210A prothrombin gene mutation
    • V. De Stefano, I. Martinelli, P.M. Mannucci, and et al. The risk of recurrent venous thromboembolism among heterozygous carriers of the G20210A prothrombin gene mutation Br. J. Haematol. 113 2001 630 635
    • (2001) Br. J. Haematol. , vol.113 , pp. 630-635
    • De Stefano, V.1    Martinelli, I.2    Mannucci, P.M.3
  • 11
    • 0034670050 scopus 로고    scopus 로고
    • Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor v gene mutation with a first episode of deep-vein thrombosis
    • P. Simioni, P. Prandoni, A.W. Lensing, and et al. Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis Blood 96 2000 3329 3333
    • (2000) Blood , vol.96 , pp. 3329-3333
    • Simioni, P.1    Prandoni, P.2    Lensing, A.W.3
  • 12
    • 77949821581 scopus 로고    scopus 로고
    • Clinical guidelines for testing for heritable thrombophilia
    • T. Baglin, E. Gray, M. Greaves, and et al. Clinical guidelines for testing for heritable thrombophilia Br. J. Haematol. 149 2010 209 220
    • (2010) Br. J. Haematol. , vol.149 , pp. 209-220
    • Baglin, T.1    Gray, E.2    Greaves, M.3
  • 13
    • 78751633462 scopus 로고    scopus 로고
    • Recommendations from the EGAPP Working Group: Routine testing for Factor v Leiden (R506Q) and prothrombin (20210G > A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members
    • Evaluation of Genomic Applications in P, Prevention Working G
    • Evaluation of Genomic Applications in P, Prevention Working G Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G > A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members Genet Med 13 2011 67 76
    • (2011) Genet Med , vol.13 , pp. 67-76
  • 14
    • 84866770483 scopus 로고    scopus 로고
    • The management of venous thromboembolic diseases and the role of thrombophilia testing: Summary of NICE Guideline CG144
    • N. Langford, G. Stansby, and L. Avital The management of venous thromboembolic diseases and the role of thrombophilia testing: summary of NICE Guideline CG144 Acute Med 11 2012 138 142
    • (2012) Acute Med , vol.11 , pp. 138-142
    • Langford, N.1    Stansby, G.2    Avital, L.3
  • 15
    • 84856802635 scopus 로고    scopus 로고
    • Antithrombotic therapy for VTE disease: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines
    • C. Kearon, E.A. Akl, A.J. Comerota, and et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines Chest 141 2 Suppl 2012 e419S e494S
    • (2012) Chest , vol.141 , Issue.2 , pp. e419S-e494S
    • Kearon, C.1    Akl, E.A.2    Comerota, A.J.3
  • 17
    • 34548611217 scopus 로고    scopus 로고
    • Hereditary thrombophilia and venous thromboembolism: Critical evaluation of the clinical implications of screening
    • L. Mazzolai, and M.A. Duchosal Hereditary thrombophilia and venous thromboembolism: critical evaluation of the clinical implications of screening Eur. J. Vasc. Endovasc. Surg. 34 2007 483 488
    • (2007) Eur. J. Vasc. Endovasc. Surg. , vol.34 , pp. 483-488
    • Mazzolai, L.1    Duchosal, M.A.2
  • 18
    • 84898826209 scopus 로고    scopus 로고
    • Reducing inpatient heritable thrombophilia testing using a clinical decision-making tool
    • T.W. Smith, D. Pi, M. Hudoba, and A.Y. Lee Reducing inpatient heritable thrombophilia testing using a clinical decision-making tool J. Clin. Pathol. 67 2014 345 349
    • (2014) J. Clin. Pathol. , vol.67 , pp. 345-349
    • Smith, T.W.1    Pi, D.2    Hudoba, M.3    Lee, A.Y.4
  • 19
    • 77249085173 scopus 로고    scopus 로고
    • Laboratory investigation of thrombophilia: The good, the bad, and the ugly
    • E.J. Favaloro, D. McDonald, and G. Lippi Laboratory investigation of thrombophilia: the good, the bad, and the ugly Semin. Thromb. Hemost. 35 2009 695 710
    • (2009) Semin. Thromb. Hemost. , vol.35 , pp. 695-710
    • Favaloro, E.J.1    McDonald, D.2    Lippi, G.3
  • 20
    • 70149120091 scopus 로고    scopus 로고
    • Recommendations on testing for thrombophilia in venous thromboembolic disease: A French consensus guideline
    • G. Pernod, C. Biron-Andreani, P.E. Morange, and et al. Recommendations on testing for thrombophilia in venous thromboembolic disease: a French consensus guideline J. Mal. Vasc. 34 2009 156 203
    • (2009) J. Mal. Vasc. , vol.34 , pp. 156-203
    • Pernod, G.1    Biron-Andreani, C.2    Morange, P.E.3
  • 21
    • 33645046565 scopus 로고    scopus 로고
    • Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence
    • F. European Genetics, E. Cardiovascular Disease, T. Research, and et al. Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence Int. Angiol. 24 2005 1 26
    • (2005) Int. Angiol. , vol.24 , pp. 1-26
    • European Genetics, F.1    Cardiovascular Disease, E.2    Research, T.3
  • 22
    • 33745788144 scopus 로고    scopus 로고
    • An evaluation of thrombophilia screening in an urban tertiary care medical center: A "real world" experience
    • J. Somma, I.I. Sussman, and J.H. Rand An evaluation of thrombophilia screening in an urban tertiary care medical center: a "real world" experience Am. J. Clin. Pathol. 126 2006 120 127
    • (2006) Am. J. Clin. Pathol. , vol.126 , pp. 120-127
    • Somma, J.1    Sussman, I.I.2    Rand, J.H.3
  • 24
    • 84936074224 scopus 로고    scopus 로고
    • Homocysteine and MTHFR mutations
    • S. Moll, and E.A. Varga Homocysteine and MTHFR mutations Circulation 132 2015 e6 e9
    • (2015) Circulation , vol.132 , pp. e6-e9
    • Moll, S.1    Varga, E.A.2
  • 25
    • 84942985738 scopus 로고    scopus 로고
    • Predictive value of factor VIII levels for recurrent venous thrombosis: Results from the MEGA follow-up study
    • Aug 13. doi:10.1111/jth.13113. [Epub ahead of print]
    • J.F. Timp, W.M. Lijfering, L.E. Flinterman, and et al. Predictive value of factor VIII levels for recurrent venous thrombosis: results from the MEGA follow-up study J Thromb Haemost 2015 Aug 13. doi:10.1111/jth.13113. [Epub ahead of print]
    • (2015) J Thromb Haemost
    • Timp, J.F.1    Lijfering, W.M.2    Flinterman, L.E.3
  • 26
    • 0033512274 scopus 로고    scopus 로고
    • International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop
    • W.A. Wilson, A.E. Gharavi, T. Koike, and et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop Arthritis Rheum. 42 1999 1309 1311
    • (1999) Arthritis Rheum. , vol.42 , pp. 1309-1311
    • Wilson, W.A.1    Gharavi, A.E.2    Koike, T.3
  • 27
    • 33344458573 scopus 로고    scopus 로고
    • International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
    • S. Miyakis, M.D. Lockshin, T. Atsumi, and et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J. Thromb. Haemost. 4 2006 295 306
    • (2006) J. Thromb. Haemost. , vol.4 , pp. 295-306
    • Miyakis, S.1    Lockshin, M.D.2    Atsumi, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.